These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 3264127

  • 1. Vaccinia colon oncolysate immunotherapy for murine hepatic metastases can be modulated with low-dose interleukin-2. Third place winner: Conrad Jobst Award.
    Barnavon Y, Iwaki H, Bash JA, Wallack MK.
    Am Surg; 1988 Dec; 54(12):696-701. PubMed ID: 3264127
    [Abstract] [Full Text] [Related]

  • 2. Treatment of murine hepatic metastases with vaccinia colon oncolysates and IL-2.
    Barnavon Y, Iwaki H, Bash JA, Brettschneider F, Hilsenbeck S, Darnell E, Wallack MK.
    J Surg Res; 1988 Dec; 45(6):523-30. PubMed ID: 3263545
    [Abstract] [Full Text] [Related]

  • 3. Immunotherapy of a vaccinia colon oncolysate prepared with interleukin-2 gene-encoded vaccinia virus and interferon-alpha increases the survival of mice bearing syngeneic colon adenocarcinoma.
    Tanaka N, Sivanandham M, Wallack MK.
    J Immunother Emphasis Tumor Immunol; 1994 Nov; 16(4):283-93. PubMed ID: 7881637
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Elimination of established liver metastases by human interleukin 2-activated natural killer cells after locoregional or systemic adoptive transfer.
    Okada K, Nannmark U, Vujanovic NL, Watkins S, Basse P, Herberman RB, Whiteside TL.
    Cancer Res; 1996 Apr 01; 56(7):1599-608. PubMed ID: 8603408
    [Abstract] [Full Text] [Related]

  • 9. Vaccinia virus-infected C-C36 colon tumor cell lysates stimulate cellular responses in vitro and protect syngeneic Balb/c mice from tumor cell challenge.
    Iwaki H, Barnavon Y, Bash JA, Wallack MK.
    J Surg Oncol; 1989 Feb 01; 40(2):90-6. PubMed ID: 2915544
    [Abstract] [Full Text] [Related]

  • 10. Intensification of antitumor effect by T helper 1-dominant adoptive immunogene therapy for advanced orthotopic colon cancer.
    Nakamori M, Iwahashi M, Nakamura M, Ueda K, Zhang X, Yamaue H.
    Clin Cancer Res; 2003 Jun 01; 9(6):2357-65. PubMed ID: 12796406
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antitumor activities of subsets of human IL-2-activated natural killer cells in solid tissues.
    Vujanovic NL, Yasumura S, Hirabayashi H, Lin WC, Watkins S, Herberman RB, Whiteside TL.
    J Immunol; 1995 Jan 01; 154(1):281-9. PubMed ID: 7995947
    [Abstract] [Full Text] [Related]

  • 16. Systematic preclinical study on the therapeutic properties of recombinant human interleukin 2 for the treatment of metastatic disease.
    Talmadge JE, Phillips H, Schindler J, Tribble H, Pennington R.
    Cancer Res; 1987 Nov 01; 47(21):5725-32. PubMed ID: 3499218
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Failed adoptive immunotherapy with tumor-specific T cells: reversal with low-dose interleukin 15 but not low-dose interleukin 2.
    Roychowdhury S, May KF, Tzou KS, Lin T, Bhatt D, Freud AG, Guimond M, Ferketich AK, Liu Y, Caligiuri MA.
    Cancer Res; 2004 Nov 01; 64(21):8062-7. PubMed ID: 15520217
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin 2 (RIL 2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and an adenocarcinoma.
    Lafreniere R, Rosenberg SA.
    J Immunol; 1985 Dec 01; 135(6):4273-80. PubMed ID: 3877766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.